Replies to post #176423 on Biotech Values

[DewDiligence]

AMGN—ODAC/CTGTAC* panels will jointly review T-Vec BLA on 4/29/15:

http://finance.yahoo.com/news/amgen-announces-fda-advisory-committees-212200072.html

*Cellular, Tissue, and Gene Therapies Advisory Committee.